(Q70755965)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7226061%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

Prognostic value of prechemotherapy skin tests in patients with metastatic breast carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7226061%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

G. N. Hortobagyi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7226061

11 March 2024

T. L. Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7226061

11 March 2024

K. D. Swenerton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7226061

11 March 2024

S. S. Legha

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7226061

11 March 2024

A. U. Buzdar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7226061

11 March 2024

G. R. Blumenschein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7226061

11 March 2024

J. U. Gutterman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7226061

11 March 2024

E. M. Hersh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7226061

11 March 2024

language of work or name

English

0 references

publication date

1 March 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7226061%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

15 March 1981

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7226061

full work available at URL

11 March 2024

number of pages

8

1 reference

based on heuristic

inferred from page(s)

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819810315%2947%3A6%3C1369%3A%3AAID-CNCR2820470622%3E3.0.CO%3B2-3

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7226061

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

11 March 2024

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

11 March 2024

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

11 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7226061%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7226061%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7226061%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

1369-1376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7226061%20AND%20SRC:MED&resulttype=core&format=json

Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.

13 October 2019

cites work

1

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Anti-keyhole limpet hemocyanin antibody in normal unsensitized individuals

11 March 2024

4

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Correlation of delayed hypersensitivity responses with chemotherapeutic results in advanced Hodgkin's disease

11 March 2024

6

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer

11 March 2024

7

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

The effect of passively administered antibody on antibody synthesis

11 March 2024

9

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Impaired immunologic reactivity and recurrence following cancer surgery

11 March 2024

10

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Sequential evaluation of general immune competence in cancer patients: Correlation with clinical course

11 March 2024

11

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

11 March 2024

12

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

National Cancer Institute Monograph

11 March 2024

13

39

205

Gutterman

1973

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

11 March 2024

14

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia

11 March 2024

19

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

The long term effects of radiation on T and B lymphocytes in the peripheral blood after regional irradiation

11 March 2024

20

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Ftorafur, adriamycin, cyclophosphamide and bcg in the treatment of metastatic breast cancer

11 March 2024

21

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.

11 March 2024

22

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Immunotherapy with BCG administered by scarification. Standardization of reactions and management of side effects

11 March 2024

23

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Nonparametric Estimation from Incomplete Observations

11 March 2024

24

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Peripheral B- and T-lymphocyte counts in patients with sarcoma and breast carcinoma

11 March 2024

25

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer

11 March 2024

26

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

The prognostic significance of peripheral lymphocyte counts in patients with breast carcinoma

11 March 2024

29

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Effect of hormone therapy on mitogenic responses of lymphocytes from patients with cancer of the breast

11 March 2024

30

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Immunologic response of atopic and normal individuals to keyhole limpet hemocyanin

11 March 2024

33

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease.

11 March 2024

34

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

11 March 2024

35

39

1152

Swenerton

1979

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters

11 March 2024

36

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

11 March 2024

38

1

191

Whitehead

1975

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

Immune responses in the treatment of advanced carcinoma of the breast. Effects of adrenalectomy

11 March 2024

39

1 reference

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19810315)47:6%3C1369::AID-CNCR2820470622%3E3.0.CO;2-3

11 March 2024

Identifiers

10.1002/1097-0142(19810315)47:6<1369::AID-CNCR2820470622>3.0.CO;2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7226061%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference